February 26, 2020 / 11:53 AM / a month ago

BRIEF-United Therapeutics Corporation Reports Q4 Adjusted Earnings Per Share $1.96

Feb 26 (Reuters) - United Therapeutics Corp:

* ORATION REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* Q4 REVENUE $311 MILLION VERSUS REFINITIV IBES ESTIMATE OF $357.8 MILLION

* QTRLY ADJUSTED EARNINGS PER SHARE $1.96

* REMUNITY SYSTEM CLEARED BY FDA FOR PHARMACY-FILLED USE; LAUNCH EXPECTED BY JULY 2020

* Q4 EARNINGS PER SHARE VIEW $2.65 — REFINITIV IBES DATA

* FY2020 REVENUE VIEW $1.29 BILLION — REFINITIV IBES DATA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below